Seagen Inc. - Common Stock (NQ:SGEN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Seagen Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

3 Top Stocks to Buy in October and Hold Forever ↗

October 02, 2023

Check out these three blue chip buys playing crucial roles in America's $6 trillion healthcare opportunity.

Via The Motley Fool

If You Invested $100 In This Stock 20 Years Ago, You Would Have $3,400 Today ↗

September 29, 2023

Via Benzinga

5 Stocks That Have Massive Upside According to Analysts

September 28, 2023

Analyst ratings are frequently a solid predictor of future stock price movement; here are five stocks that analysts believe have massive upside.

Via MarketBeat

Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher ↗

September 27, 2023

These pharma stocks could boom in the coming years, riding their diversified pipelines with massive addressable markets higher.

Via InvestorPlace

September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average ↗

September 27, 2023

The September market downturn is spreading like wildfire across various sectors, with only a handful of stocks managing to maintain the positive trend seen in recent months.

Via Benzinga

Topics Stocks

Seagen Unusual Options Activity ↗

September 27, 2023

Via Benzinga

Seagen Inc. (NASDAQ: SGEN) Climbs to New 52-Week High

September 25, 2023

Via Investor Brand Network

(SGEN) - Analyzing Seagen's Short Interest ↗

September 20, 2023

Via Benzinga

Why Is Seagen Stock Trading Higher Today? ↗

September 22, 2023

Seagen Inc (NASDAQ: SGEN) and Astellas Pharma Inc (OTC: ALPMF) (OTC:

Via Benzinga

Seagen Inc. (NASDAQ: SGEN) Sets New 52-Week High in Friday Session

September 22, 2023

Via Investor Brand Network

Seagen Pops After Scoring A 'Must-Win' For Its $43 Billion Takeover By Pfizer ↗

September 22, 2023

The companies tested a key combination in patients with previously untreated bladder cancer.

Via Investor's Business Daily

PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial

September 22, 2023

From Seagen Inc.

Via Business Wire

Check Out What Whales Are Doing With SGEN ↗

September 19, 2023

Via Benzinga

Check Out What Whales Are Doing With SGEN ↗

September 14, 2023

Via Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today ↗

September 12, 2023

Via Benzinga

Check Out What Whales Are Doing With SGEN ↗

September 06, 2023

Via Benzinga

Flee to Healthcare Stocks if Recession Rears its Head?

September 20, 2023

In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.

Via MarketBeat

Topics Economy

10 Health Care Stocks Whale Activity In Today's Session ↗

September 15, 2023

Via Benzinga

Why Shares of Iovance Biotherapeutics Dropped Thursday ↗

September 14, 2023

The biotech stock's lead therapy is looking at some competition.

Via The Motley Fool

The 3 Most Undervalued Pharma Stocks to Buy in September 2023 ↗

September 14, 2023

Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now.

Via InvestorPlace

Looking Into Seagen's Recent Short Interest ↗

August 31, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Seagen Stock In The Last 10 Years ↗

August 25, 2023

Via Benzinga

Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today? ↗

September 07, 2023

Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called...

Via Benzinga

Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst ↗

September 05, 2023

RBC Capital Markets has initiated coverage on Pyxis Oncology Inc (NASDAQ: PYXS) with an Outperform rating and a

Via Benzinga

Why Shares of Zai Lab Limited Were Jumping on Tuesday ↗

September 05, 2023

Zai Lab's shares benefited from positive clinical trial news.

Via The Motley Fool

Encouraging Data From Seagen/Genmab's Cervical Cancer Study - Tivdak Success Sets Stage For New Indications ↗

September 05, 2023

Seagen Inc (NASDAQ: SGEN) and Genmab A/S (NASDAQ: GMAB) released topline data from the Phase 3 innovaTV 301 global trial in recurrent or metastatic cervical cancer patients with disease progression on...

Via Benzinga

Seagen and Genmab Announce TIVDAK® (tisotumab vedotin-tftv) Improved Overall Survival in Patients With Recurrent or Metastatic Cervical Cancer Compared With Chemotherapy Alone

September 04, 2023

From Seagen Inc.

Via Business Wire

Genmab and Seagen Announce That TIVDAK® (tisotumab vedotin-tftv) Met its Primary Endpoint of Improved Overall Survival in Patients with Recurrent or Metastatic Cervical Cancer Compared to Chemotherapy

September 04, 2023

From Genmab A/S

Via Business Wire

Ambrx Biopharma Has Surged 483% This Year. But It Could Just Be Getting Started. ↗

August 31, 2023

The company has another update on its prostate cancer program that could further prod shares.

Via Investor's Business Daily

3 Fantastic Stocks to Buy in a New Bull Market ↗

August 20, 2023

These stocks could be just the ticket if a sustained new bull market is beginning.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.